Slideshow

Juvenile Idiopathic Arthritis: What’s the Optimal Treatment Target?

How best to determine clinically inactive disease: Wallace’s preliminary criteria versus the clinical juvenile arthritis disease activity score.

Reference1. Shoop-Worrall SJ, Verstappen SM, McDonagh JE, et al. Long term outcomes following achievement of clinically inactive disease in juvenile idiopathic arthritis: the importance of definition. Arthritis Rheumatol. 2018 Apr 12. doi: 10.1002/art.40519. [Epub ahead of print]

Related Videos
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
Related Content
Adwoa Dansoa Tabi-Amponsah, PhD candidate, Department of Medicine, The Faculty of Medical and Health Sciences, University of Auckland, New Zealand
October 9th 2024

Simplified Gout Remission Definition Feasible, Valid

Victoria Johnson
Emerging Agents in the Treatment of Rheumatic Diseases
October 2nd 2023

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR Philip J. Mease, MD
HCPLive Rheumatology Month in Review
October 6th 2024

Rheumatology Month in Review: September 2024

Victoria Johnson
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
August 31st 2023

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR John B. Boone, MD, FACR Madelaine Feldman MD, FACR
Credit: Allegheny Health Network
October 4th 2024

Unlocking the Mystery at AHN Autoimmunity Institute

Allegheny Health Network
Cell Therapies Hope to be Next Frontier for Alzheimer Disease
October 4th 2024

Faster Weight Loss on Anti-Obesity Medication Correlated With Lower Risk of Gout

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.